We are building One Zyme with a team that brings together deep experience across biopharma, big tech, and venture capital. We know the workflows, pressures, and strategic decisions this industry faces because we have lived them from multiple angles: building companies, evaluating opportunities, advancing science, and deploying technology at scale.
One Zyme is purpose-built for biopharma. Not a general-purpose AI layer. Not a repackaged legacy database. A focused intelligence platform designed to support the full range of decisions that shape the industry, from business development and competitive intelligence to new product planning, R&D strategy, clinical development, and beyond.
We believe AI has brought about a moment when biopharma intelligence will change radically. The databases that served the industry for decades were built for a different era: static, fragmented, and manually searched. AI makes something new possible: dynamic intelligence that will do much of the work for you and enable better, faster decision-making. One Zyme exists to help the industry take the leap into that future.
That is exactly the role we set out to play. We didn't want to be one more database or one more dashboard. We wanted to be the one catalyst that changes how the entire industry works, compressing weeks of fragmented research into minutes of decision-ready intelligence.
So we named the company for it. One Zyme: a single catalyst for the business of biopharma.
We are building One Zyme for the long term. Our decisions aren't driven by short-term needs, but by what serves the lasting interest of the company and our customers.
We care more about getting to the right answer than defending the comfortable one. Our job is to follow the evidence wherever it leads.
No workflow, data source, market map, or strategic belief gets a free pass because “that's how it's always been done.”
One Zyme is backed by top-tier venture firms and built by a team that has shipped at the frontier of AI and operated inside the industry it serves.
We're funded by leading VC firms that back category-defining companies, giving us the runway and conviction to build the intelligence layer biopharma actually needs.
Our team comes out of the leading technology companies, top venture firms, and major pharmaceutical organizations, so the product is engineered at a frontier-AI standard and grounded in how the industry really operates.
Book a 30-minute briefing. We'll run a live search on a target of your choice and walk you through intelligence you can take straight to your team.
